Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan

Obesity Research and Clinical Practice

Volumn 8, Issue 5, 2014, Pages e466-e475

  Muramoto, Akiko ^a   Matsushita, Madoka ^a,b   Kato, Ayako ^a   Yamamoto, Naoki ^b   Koike, George ^d   Nakamura, Masakazu ^c   Numata, Takeyuki ^e   Tamakoshi, Akiko ^f   Tsushita, Kazuyo ^a  

^a Aichi Health Promotion Foundation   (Japan)

^b TOYOTA MOTOR CORPORATION   (Japan)

^c Osaka Center for Cancer and Cardiovascular Diseases Prevention   (Japan)

^d Fukuoka City Medical Association Hospital   (Japan)

^e Okayama Southern Institute of Health   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Goal setting; Health counseling; Japanese; Lifestyle intervention; Obesity; Overweight

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ABDOMINAL CIRCUMFERENCE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPAN; JAPANESE (PEOPLE); LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD; COMPLICATION; CONTROLLED CLINICAL TRIAL; HEALTH; LIFESTYLE; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; WEIGHT LOSS PROGRAM;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HEALTH; HUMANS; JAPAN; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); OVERWEIGHT; RISK FACTORS; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84908041063     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2013.10.003     Document Type: Article

References (19)

1. J. Stevens, J. Cai, E.R. Pamuk, D.F. Williamson, M.J. Thun, and J.L. Wood The effect of age on the association between body-mass index and mortality N Engl J Med 338 1998 1 7
2. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, and V.S. Bales Prevalence of obesity, diabetes, and obesity-related health risk factors JAMA 289 2003 76 79
3. H.M. Lakka, D.E. Laaksone, and T.A. Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
4. B. Isomaa, P. Almgren, and T. Tuomi Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689
5. S. Malik, N.D. Wong, and S.S. Franklin Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250
6. World Health Organization Obesity. preventing and managing the global epidemic 1997 Report of a WHO Consultation on Obesity Genova
7. The Examination Committee of Criteria for 'Obesity Disease' in Japan Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan Circ J 66 2002 987 992
8. Y. Matsuzawa Metabolic syndrome-definition and diagnostic criteria in Japan J Jpn Soc Int Med 94 2005 188 203
9. S. Mizushima, and K. Tsushita New strategy on prevention and control of noncommunicable lifestyle-related diseases focusing on metabolic syndrome in Japan Asian Perspectives and Evidence on Health Promotion and Education 2011 31 39
10. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
11. J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, and P. Ilanne-Parikka Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350
12. The National Heart, Lung, and Blood Institute Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report 1998
13. Australian Government National Health and Medical Research Council New clinical practice guidelines for managing overweight and obesity 2013
14. A. Kashiwagi, M. Kasuga, E. Araki, Y. Oka, T. Hanafusa, and T. Ito Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values Diabetol Int 3 2012 8 10
15. K.F. Eriksson, and F. Lindgärde Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study Diabetologia 34 1991 891 898
16. G.D. Foster, T.A. Wadden, R.A. Vogt, and G. Brewer What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes J Consult Clin Psychol 65 1997 79 85
17. J.E. Neter, B.E. Stam, F.J. Kok, D.E. Grobbee, and J.M. Geleijnse Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials Hypertension 42 2003 878 884
18. T.A. Wadden, D.A. Anderson, and G.D. Foster Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions Obes Res 2 1999 170 178
19. R.R. Wing, R. Koeske, L.H. Epstein, P. Nowalk, W. Gooding, and D. Becker Long-term effects of modest weight loss in type II diabetic patients Arch Intern Med 147 1987 1749 1753